Overview

Detailed Summary

Boston Bio Systems Limited is primarily engaged in trading medical equipment, testing kits, and instruments.
Originally founded in 1995, the company started with share broking and trading in shares and derivatives.
The company's shift to trading medical goods suggests a strategic realignment towards the healthcare sector.
There is no detailed updated information on its current performance or market position, indicating limited available data.

Sector: Healthcare Services
Industry: Healthcare Service Provider
Market Cap: 5 Cr
Volatility: Low Risk
P/E Ratio: -11.9
Industry P/E: 54.2
PEG Ratio: —
P/B Ratio: 0.9
52W High: 11.89
52W Low: 5.13

Sales CAGR

1Y: —
3Y: —
5Y: —
10Y: -20.38%

Profit CAGR

1Y: -292.86%
3Y: —
5Y: —
10Y: —

ROE

TTM: -7.73%
3Y: -3.64%
5Y: -2.71%
10Y: —

ROCE

TTM: -3.03%
3Y: -2.90%
5Y: -2.27%
10Y: —

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ZDHJERK		28.77	12 Cr	43.59	1.18	0.00	0.99	1.37	0.76
DLCL		14.07	9 Cr	14.66	0.62	0.00	4.53	3.40	2.92
CTLLAB		36.00	8 Cr	18.95	0.93	0.00	5.19	7.65	4.22
GIANLIFE		6.44	7 Cr	-6.85	0.36	0.00	-3.76	-1.02	-2.81
LOOKS		6.28	6 Cr	-1.26	0.42	0.00	1.08	1.15	1.31
TATIASKYLN		4.30	5 Cr	-47.78	0.43	0.00	-0.61	-0.00	-0.57
BOSTONBIO		7.12	5 Cr	-11.87	0.88	0.00	-7.73	-3.03	-2.75
Median: 7 Co.	—	7.12	7 Cr	-1.26	0.62	0.00	0.99	1.15	0.76

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	0.00	0.00	0.00	0.00	0.00	0.00	0.19	0.18	0.24	0.06
Expenses	0.00	0.00	0.14	0.00	0.01	0.05	0.68	0.10	0.19	0.07
Operating Profit	0.00	0.00	-0.14	0.00	-0.01	-0.05	-0.49	0.05	0.05	-0.01
OPM %	—	—	—	—	—	—	-257.89	27.78	20.83	-16.67
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.05	0.03
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	0.00	0.00	-0.14	0.00	-0.01	-0.05	-0.49	0.05	0.05	-0.01
Tax %	—	—	0.00	—	0.00	0.00	0.00	20.00	20.00	0.00
Net Profit	0.00	0.00	-0.14	0.00	-0.01	-0.05	-0.49	0.04	0.04	-0.01
EPS in Rs	0.00	0.00	-0.20	0.00	-0.01	-0.07	-0.70	0.06	0.06	-0.02

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	0.05	0.06	1.50	0.53	0.70	0.00	0.00	0.00	0.19	0.37
Expenses	0.05	0.06	1.50	0.53	0.70	0.00	0.00	0.14	0.74	0.84
Operating Profit	-0.00	0.00	0.00	0.00	0.00	-0.00	-0.00	-0.14	-0.55	-0.50
OPM %	-4.32	1.28	0.07	0.26	0.05	—	—	—	-284.31	-135.14
Other Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	NaN
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	0.00	0.00	0.00	0.00	0.00	-0.00	-0.00	-0.14	-0.55	-0.50
Tax %	323.69	205.61	253.16	323.65	3,045.76	—	—	—	—	-2.00
Net Profit	0.00	0.00	0.00	0.00	0.00	-0.00	-0.00	-0.14	-0.55	-0.51
EPS in Rs	-0.01	-0.07	0.01	-0.01	0.04	—	0.00	-0.20	-0.78	-0.60
Dividend Payout %	—	—	—	—	—	—	—	—	—	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00	7.00
Reserves	-0.40	-0.40	-0.40	-0.40	-0.40	-0.40	-0.41	-0.41	-0.55	-1.10
Borrowings	0.12	0.12	0.12	0.87	0.87	0.87	0.87	0.87	0.87	5.44
Other Liabilities	-0.00	0.00	0.00	1.46	1.90	2.60	3.11	3.11	3.25	3.56
Total Liabilities	6.71	6.72	6.72	8.93	9.36	10	11	11	11	15
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	6.71	6.71	6.71	8.93	9.36	10	11	11	11	15
Total Assets	6.71	6.72	6.72	8.93	9.36	10	11	11	11	15

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.03	0.00	0.97	-0.03	-0.02	0.13	-0.00	-0.00	0.00	-4.59
Cash from Investing Activity	0.00	-0.00	-0.91	0.00	0.00	-0.08	0.00	0.00	0.00	0.00
Cash from Financing Activity	-0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.58
Net Cash Flow	0.00	-0.00	0.06	-0.03	-0.02	0.05	-0.00	-0.00	0.00	-0.01

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	2.14%	2.14%	2.14%	2.14%	2.14%	2.14%	2.14%	2.14%	2.14%	2.14%	2.14%	2.14%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	97.86%	97.86%	97.86%	97.86%	97.86%	97.86%	97.86%	97.86%	97.86%	97.86%	97.86%	97.86%
Total Shareholders	1,141	1,141	1,141	1,141	1,141	1,141	1,141	1,141	1,147	1,295	1,385	1,410

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.